Zantac (Ranitidine) Litigation and Recall
Mike McGlamry was appointed by the Honorable Robin L. Rosenberg to the Initial Census Team in the Zantac (Ranitidine) Products Liability Litigation in the United States District Court for the Southern District of Florida. The Initial Census Team was formed to create an early census process that requires claimants to show that they were exposed to and injured by Zantac by submitting proof of their cancer diagnosis and proof that they used Zantac/ranitidine products. On April 3, 2020, Mike was also appointed by the Court to be responsible for all filings and submissions on behalf of the plaintiffs, and is further responsible for directing all work related to discovery during the COVID-19 crisis. We are proud to be a part of this team and look forward to helping those harmed by Zantac/Ranitidine usage.